VT News
John Jarratt

John Jarratt

Ask VT AI
View News Summary
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • Texas teen charged with murder allowed to graduate high school, sparking controversy over racial bias.
  • Debate erupts over Quail Hollow's character ahead of 2025 PGA Championship, with some criticizing course changes and others defending its challenging layout.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • Texas teen charged with murder allowed to graduate high school, sparking controversy over racial bias.
  • Debate erupts over Quail Hollow's character ahead of 2025 PGA Championship, with some criticizing course changes and others defending its challenging layout.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from John Jarratt

Top Topics

Trending in U.S.

World

Sport